StockMacro
Menu

Standard BioTools

LAB on XNAS, Standard BioTools Inc.

Measures activity, not value. Not investment advice.

New positions, last 12 months

81

+16% vs the 12 months before

Positions closed, last 12 months

124

+94% vs the 12 months before

Net, last 12 months

-43

new positions minus positions closed

Sharp changes

3

many funds opening a new position

Window

What usually follows Change in institutional holders was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it

Largest holders over the last 8 quarters

Shares reported on Form 13F at each quarter end; the 10 largest holders of Q3 2026. "–": no full report for that quarter (not filed yet, or positions kept confidential)
InstitutionTrendQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Casdin Capital, LLC71.3M76.1M76.1M77.6M88.8M88.8M88.8M88.8M
Viking Global Investors LP58.7M58.7M58.7M58.7M58.7M58.7M58.7M58.7M
Long Focus Capital Management, LLC06.7M10.1M11.4M12.7M16.0M23.5M25.3M
Mak Capital One LLC02.8M5.6M15.9M19.3M26.2M28.8M25.0M
Vanguard Capital Management LLC–––––12.8M12.3M12.5M
BlackRock, Inc.24.9M24.6M24.8M24.9M25.5M24.8M8.3M8.3M
Hollow Brook Wealth Management LLC5.5M5.6M5.6M5.8M5.6M5.7M5.5M5.2M
Qube Research & Technologies Ltd491K420K441K283K217K704K4.8M4.9M
Neuberger Berman Group LLC4.6M4.5M4.5M4.7M4.6M4.7M5.0M4.3M
D. E. Shaw & Co., Inc.00000199K2.8M4.0M
New positions: 8 vs positions closed: 41 in the quarter from 1 Jul 2026

Form 13F holdings by quarter end.

See the numbers
Quarter of Jul 2026: new positions 8, positions closed 41
Quarter of Apr 2026: new positions 39, positions closed 49
Quarter of Jan 2026: new positions 18, positions closed 22
Quarter of Oct 2025: new positions 16, positions closed 12
Quarter of Jul 2025: new positions 9, positions closed 16
Quarter of Apr 2025: new positions 24, positions closed 13
Quarter of Jan 2025: new positions 21, positions closed 17
Quarter of Oct 2024: new positions 16, positions closed 18
Quarter of Jul 2024: new positions 16, positions closed 21
Quarter of Apr 2024: new positions 31, positions closed 34
Quarter of Jan 2024: new positions 67, positions closed 12
Quarter of Oct 2023: new positions 21, positions closed 11
Quarter of Jul 2023: new positions 14, positions closed 8
Quarter of Apr 2023: new positions 15, positions closed 13
Quarter of Jan 2023: new positions 11, positions closed 14
Quarter of Oct 2022: new positions 10, positions closed 11
Quarter of Jul 2022: new positions 4, positions closed 22
Quarter of Apr 2022: new positions 24, positions closed 35
Quarter of Jan 2022: new positions 8, positions closed 23
Quarter of Oct 2021: new positions 17, positions closed 20
Quarter of Jul 2021: new positions 19, positions closed 10
Quarter of Apr 2021: new positions 8, positions closed 31
Quarter of Jan 2021: new positions 24, positions closed 30
Quarter of Oct 2020: new positions 31, positions closed 26
Quarter of Jul 2020: new positions 39, positions closed 19
Quarter of Apr 2020: new positions 27, positions closed 17
Quarter of Jan 2020: new positions 14, positions closed 12
Quarter of Oct 2019: new positions 9, positions closed 36
Quarter of Jul 2019: new positions 20, positions closed 28
Quarter of Apr 2019: new positions 23, positions closed 22
Quarter of Jan 2019: new positions 45, positions closed 16
Quarter of Oct 2018: new positions 29, positions closed 9
Quarter of Jul 2018: new positions 5, positions closed 10
Quarter of Apr 2018: new positions 11, positions closed 11
Quarter of Jan 2018: new positions 11, positions closed 8
Quarter of Oct 2017: new positions 8, positions closed 10
Quarter of Jul 2017: new positions 5, positions closed 6
Quarter of Apr 2017: new positions 8, positions closed 8
Quarter of Jan 2017: new positions 11, positions closed 9
Quarter of Oct 2016: new positions 9, positions closed 22

What the numbers say

  • New positions: 8 vs positions closed: 41 in the quarter from 1 Jul 2026.
  • Net new institutional positions over 12 months: -43, number 805 of 820 Health Care companies with data (median 14).
  • 3 sharp changes in all loaded history (many funds opening a new position).
  • 13F moves in the last four quarters: the largest is added, 169 (32%).
13F moves in the last four quarters: the largest is added, 169 (32%)
See the numbers
Added169 (32%)
Cut158 (30%)
Closed124 (23%)
Opened81 (15%)

Every measure from this source

5 years, by the period each figure describes

13F positions. 104 in the latest period, -28% on a year earlier.
Value held by 13F filers. $210.9M in the latest period, -43% on a year earlier.
Shares held by 13F filers. 289.4M in the latest period, +1.4% on a year earlier.
Net change in shares held. 5.1M in the last 12 months, -41% on the year before.
13F filers adding shares. 169 in the last 12 months, +0.6% on the year before.
13F filers cutting shares. 158 in the last 12 months, -6.5% on the year before.
Institutions opening a position. 81 in the last 12 months, +16% on the year before.
13F filers closing a position. 124 in the last 12 months, +94% on the year before.
Share held by the 10 largest holders (median stock). +82% in the latest period, +0.9% on a year earlier.

Sharp changes

3 in all loaded history, strongest first

Standard BioTools saw 67 13F filers open a new position in the quarter ended 31 Mar 2024, 5.6× the same quarter last year.

Many funds opening a new position, became public on 15 May 2024

Same quarter last year: 12; its normal quarter is 13.

See the evidence
This period
67 (the quarter ended 31 Mar 2024)
Normal quarter (median of 8 earlier)
13
Typical spread (median absolute deviation)
4
How far from its usual level
+9.1
Same quarter last year
12
History used
3,835 days
2022-03-31: 82022-06-30: 242022-09-30: 42022-12-31: 102023-03-31: 122023-06-30: 152023-09-30: 142023-12-31: 222024-03-31: 67
the quarter ended 31 Mar 20248 earlier quartersnormal: 13

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Standard BioTools saw 45 13F filers open a new position in the quarter ended 31 Mar 2019, 4.1× the same quarter last year.

Many funds opening a new position, became public on 15 May 2019

Same quarter last year: 11; its normal quarter is 10.

See the evidence
This period
45 (the quarter ended 31 Mar 2019)
Normal quarter (median of 8 earlier)
10
Typical spread (median absolute deviation)
2
How far from its usual level
+11.7
Same quarter last year
11
History used
2,008 days
2017-03-31: 122017-06-30: 82017-09-30: 52017-12-31: 92018-03-31: 112018-06-30: 122018-09-30: 52018-12-31: 292019-03-31: 45
the quarter ended 31 Mar 20198 earlier quartersnormal: 10

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Standard BioTools saw 29 13F filers open a new position in the quarter ended 31 Dec 2018, 3.2× the same quarter last year.

Many funds opening a new position, became public on 14 Feb 2019

Same quarter last year: 9; its normal quarter is 9.

See the evidence
This period
29 (the quarter ended 31 Dec 2018)
Normal quarter (median of 8 earlier)
9
Typical spread (median absolute deviation)
2.5
How far from its usual level
+5.4
Same quarter last year
9
History used
1,918 days
2016-12-31: 92017-03-31: 122017-06-30: 82017-09-30: 52017-12-31: 92018-03-31: 112018-06-30: 122018-09-30: 52018-12-31: 29
the quarter ended 31 Dec 20188 earlier quartersnormal: 9

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

The records

Newest first, by the day each became public

No records in all loaded history with these filters.